A lifesaving device that detects silent heart attacks Akash Manoj

When I was 13,

I lost my grandfather
to a silent heart attack.

What happened to be more
shocking was that at 75,

grandpa was really normal,
healthy and energetic,

but he was diabetic.

Learning all of this was so painful

that I decided to go out on a war
against this deadly killer

and see what could be done.

It was shocking to discover
the results of recent studies

that have shown an estimate
of nearly eight million people

who die from heart attacks every year.

Heart attacks occur for many reasons,

but most often, they occur
when arteries get clogged,

blood flow is cut off

and oxygen-starved cells
in the heart muscles start to die.

You may know the common
symptoms of a heart attack:

chest pain, arm pain, shortness
of breath, fatigue, et cetera …

but there is a type of heart attack
that is quite common,

just as deadly,

but harder to detect
because the symptoms are silent.

People having silent heart attacks
just don’t realize what’s happening,

so they’re not seeking medical attention,

which means they’re less likely
to receive the treatment that they need

at the critical moment.

And even if they do
get to the hospital by chance,

either before or after
they are struck by a heart attack,

they might have to go through one or more
of these time-consuming, expensive tests

and treatments,

which are currently considered
the gold standards

of heart-attack diagnosis.

The greater concern, however,

is that these silent heart attacks
account for nearly 45 percent

of all heart attacks.

Patients with diabetes and similar
disorders suffer from nerve damage

that prevents them from feeling
the sort of pain

that usually signals to someone

that he or she may be having
a heart attack.

Which means they suffer
the damage of a heart attack

without even knowing or feeling anything.

These already at-risk patients
suffer from nerve damage,

and they do not get
immediate medical care.

They do not know anything before
an unlikely event is about to occur.

My grandfather
was an at-risk patient, too.

I probed this issue further –

read as much as I could
to understand the heart,

met researchers
and worked across labs in India.

And finally, after three long years
of persistent research,

what I have to share with the world today
is a promising solution.

A noninvasive device that is inexpensive,

portable, wearable by at-risk
patients at all times.

It greatly reduces
the need for a blood test

and works 24/7, collecting
and analyzing data at preset intervals.

And all this data is collected
for a single purpose:

detecting heart attacks as they occur.

This is a very promising solution
that might help us in the future.

You may not know how intelligent
your heart really is.

It tries to communicate to your body
multiple times before failing,

by indicating symptoms like chest pain.

These symptoms are triggered
when the heart loses out

on oxygen-rich blood flow.

But remember I told you
about the nerve damage.

It silences these symptoms
before a silent heart attack,

which makes it even deadlier.

And you may not even know
the common symptoms.

Meanwhile, the heart also sends out
certain biomarkers –

cardiac biomarkers or proteins
that are SOS messages –

in the form of SOS messages –

into your bloodstream,

indicating that the heart is at risk.

As it gets riskier and riskier,

the concentrations
of these cardiac biomarker proteins

keep increasing abysmally.

My device solely relies on this data.

The key is that these cardiac
biomarkers are found

in one of the earliest
stages of a heart attack,

when someone is almost sure to survive

if he or she gets prompt care.

And my device is solely based
on that basis.

And here’s how my device works.

A silicon patch is worn around your wrist
or placed near your chest.

Without having to prick your skin
for a biomarker blood test,

this patch can spot, isolate and track
a heart-attack specific biomarker

called H-FABP,

and alerts you if and when it reaches
a critical level in your bloodstream –

a process that’s much simpler, easier
and cheaper than conventional methods

of heart-attack diagnosis.

By checking on biomarker
concentration data,

a system like this,
with advanced research in the future,

could significantly reduce the need
for an at-risk patient to go to a doctor

for a biomarker blood test,

because the device
could be worn at all times,

sensing biomarker elevations in real time.

Thus, if the device senses the biomarker
levels going beyond the critical point,

the at-risk patient could be warned
of an impending cardiac arrest

and that he or she needs
immediate medical attention.

Although the device may not be able
to provide the patient

with the complete analysis
of the cardiac injury,

it might be of immense help

in actually indicating
that the patient is in danger,

so that the patient can be alarmed

and know that immediate care is crucial.

Every at-risk patient will now receive
more time to survive

and reach out for medical help.

Consequently, they don’t have to go

for expensive and invasive
medical treatments

that would otherwise be necessary
after a heart attack.

When I got my device tested
on at-risk patients under observation,

results from the clinical validation tests

certified close to a 96 percent
accuracy and sensitivity.

I intend to make my device available
to people in two variants:

one which gives digital analysis
of the biomarker levels

and a simpler version
for the people in rural areas

which simply vibrates when the biomarker
levels go beyond the critical point.

When we look at our progress
in cardiac health care today,

it is more of sick care than preventative
self-care and technology.

We literally wait
for the heart attack to occur

and put our vast majority of resources
into post-care treatment.

But by then, irreversible damage
will already be done.

I firmly believe it’s time
for us to rethink medicine.

We must establish proactive
health-care technologies.

A change must be brought out
not 10 years from now,

not five years from now,

but today.

And so, hopefully, one day,

with the help of these devices,

someone else won’t lose
his or her grandfather just like I did.

Thank you so much.

(Applause)

Thank you.

(Applause)

Thank you.

在我 13 岁的时候,

我的
祖父死于无声的心脏病发作。


令人震惊的是,75

岁的爷爷真的很正常,
身体健康,精力充沛,

但他却患有糖尿病。

了解到这一切让我感到非常痛苦

,以至于我决定
与这个致命的杀手开战

,看看能做些什么。

令人震惊的是
,最近的研究

结果显示,估计每年
有近 800 万人

死于心脏病发作。

心脏病发作的原因有很多,

但最常见的情况
是动脉阻塞、

血流中断

以及
心肌中缺氧的细胞开始死亡。

您可能知道
心脏病发作的常见症状:

胸痛、手臂疼痛、
呼吸急促、疲劳等等……

但有一种心脏病
发作很常见,

同样致命,

但更难被发现,
因为 症状是沉默的。

患有无症状心脏病发作的人
只是没有意识到发生了什么,

所以他们没有寻求医疗护理,

这意味着他们在关键时刻不太
可能接受他们需要的治疗

即使他们在心脏病发作之前或之后
偶然去医院,

他们也可能不得不接受一项或
多项这些目前被认为是黄金的耗时、昂贵的检查

和治疗

心脏病的诊断标准。

然而,更令人担忧的

是,这些无声心脏病发作

占所有心脏病发作的近 45%。

患有糖尿病和类似
疾病的患者会遭受神经损伤

,这使他们无法

感受到通常向某人发出的信号,

表明他或她可能
患有心脏病。

这意味着他们

不知道或感觉不到任何事情的情况下遭受心脏病发作的伤害。

这些已经处于危险中的患者
遭受神经损伤

,他们没有得到
立即的医疗护理。


一个不太可能发生的事件即将发生之前,他们什么都不知道。

我的祖父
也是一个高危患者。

我进一步探讨了这个问题——

尽可能多地阅读
以了解心脏,

会见研究人员
并在印度的实验室工作。

最后,经过三年
的持续研究,

我今天要与世界分享的
是一个很有前景的解决方案。

一种价格低廉、

便携、高危患者可随时佩戴的无创设备

它大大减少
了对血液测试的需求,

并且可以 24/7 全天候工作,
以预设的时间间隔收集和分析数据。

所有这些数据都是
为了一个目的而收集的:在

心脏病发作时检测它们。

这是一个非常有前途的解决
方案,将来可能会对我们有所帮助。

你可能不
知道你的心到底有多聪明。

它会在失败前多次尝试与您的身体交流

通过指示胸痛等症状。

当心脏

失去富含氧气的血流时,就会触发这些症状。

但请记住我告诉过
你神经损伤。


在无声心脏病发作之前使这些症状保持沉默,

这使其更加致命。

你甚至可能不
知道常见的症状。

同时,心脏还会以 SOS 信息的形式将
某些生物标志物(

心脏生物标志物或蛋白质
,即 SOS 信息)

发送

到您的血液中,

表明心脏处于危险之中。

随着风险越来越大

,这些心脏生物标志物蛋白的浓度

不断增加。

我的设备完全依赖这些数据。

关键是这些心脏
生物标志物是


心脏病发作的最早阶段之一发现的,

如果有人得到及时护理,几乎可以肯定会活下来

而我的设备完全
基于这个基础。

这就是我的设备的工作原理。

硅胶贴片戴在手腕上
或放在胸部附近。

无需刺破您的皮肤
进行生物标志物血液测试,

该贴片可以发现、隔离和跟踪称为 H-FABP
的心脏病发作特异性生物标志物

并在它达到
您血液中的临界水平时提醒您 -

这个过程是 比传统的心脏病诊断方法更简单、更容易
、更便宜

通过检查生物标志物
浓度数据,

这样的系统
以及未来的高级研究

可以显着
减少高危患者去看医生

进行生物标志物血液测试的需要,

因为该设备
可以随时佩戴 ,

实时感知生物标志物的升高。

因此,如果设备检测到生物标志物
水平超过临界点,

则可能会警告处于危险中的患者
即将发生心脏骤停

,并且他或她需要
立即就医。

尽管该设备可能无法
为患者

提供对心脏损伤的完整分析

但它可能会

在实际
表明患者处于危险中时提供巨大帮助,

从而使患者能够警觉

并知道立即护理至关重要 .

现在,每位高危患者都将有
更多时间生存

并寻求医疗帮助。

因此,他们不必在心脏病发作后

进行昂贵的侵入性
医疗治疗

当我
在观察中的高危患者身上测试我的设备时,

临床验证测试的结果

证明其
准确度和灵敏度接近 96%。

我打算让我的设备有
两种变体可供人们使用:

一种
是对生物标志物水平进行数字分析,

另一种是为农村地区的人们提供更简单的版本

当生物标志物水平超过临界点时,它只会振动

当我们审视我们
今天在心脏保健方面取得的进展时

,更多的是疾病护理,而不是预防性的
自我保健和技术。

我们实际上是在
等待心脏病发作

,并将我们的绝大多数资源
用于后期护理治疗。

但到那时,已经造成不可逆转的
损害。

我坚信现在是
我们重新思考医学的时候了。

我们必须建立积极的
医疗保健技术。

改变必须
在 10 年后,

不是 5 年后,

而是今天。

因此,希望有一天,

在这些设备的帮助下,

其他人不会
像我一样失去他或她的祖父。

太感谢了。

(掌声)

谢谢。

(掌声)

谢谢。